Office of Research & Development |
![]() ![]() |
Project Number: | I01CX001449-01A1 |
Title: | Frequent, Low-Dose Erythropoietin: A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Therapy in Patients with Chronic Kidney Disease |
Principal Investigator: | Mark S. Segal |
Location: | Gainesville, FL |
Congressional District Code: | 3 |
Research Service: | Clinical Science R&D |
Project Period: | October 2017 - September 2022 |
FY 2022 Funding Amount: | $0 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |